A GLOBALly integrated Pharmaceutical Contract Research Organization (CRO)

Are you a pharmaceutical scientist or research leader struggling to manage the increasing cost and complexity of drug studies?  You’ve come to the right place.

Founded in 2001, Frontage is a pharmaceutical Contract Research Organization (CRO) that solves difficult problems with highly talented people at levels of quality and value few competitors can match.

Our track record of success in delivering projects on time and on budget gives new customers confidence in our capabilities and brings over 80% of existing clients back for additional work.

Contact Us to discuss our services for your pharmaceutical or medical device project.  

Frontage is an international company with locations in PA, NJ, Shanghai, Beijing, and Zhengzhou.  Visit the Frontage China website

When you choose Frontage, we promise you a friendly, collaborative environment and a full range of services provided by skilled professionals.  Our entire organization is geared toward flexibility and responsiveness, keeping your project front and center.

What's new

• Meet Frontage Bioanalytical Experts at ASMS 2013 to discover our latest findings May 22, 2013
• David Reiner, Medical Director, Frontage Clinical Research to speak at Optimizing Clinical Research Performance May 19-21 Boston, MA
• View updated Corporate presentation April 8, 2013
• Frontage expands pain medication development services April 2, 2013
• Frontage successfully concludes first FDA inspection to combine clinical and bioanalytical activities in China March 25, 2013
• Frontage growth recognized in recent article about Pennsylvania and New Jersey CROs February 15, 2013
• More News,  Brochures, Newsletter > Subscribe

Scientific Resources

• Newly Updated! Current List of Validated Methods
• A Generic Approach for Absolute Quantitation of the Monoclonal Antibody BAN2401 in Human Serum Using Immunocapture and Mass Spectrometric Detection
• CMC Group Publishes Perspective on Quality by Design

• Determination of an Endogenous Biomarker - 4β-Hydroxycholesterol in K2EDTA Human Plasma by  LC-MS/MS

• Determination of Entecavir in Human Matrices: Comparison of Dried Blood Spots (DBS) and Plasma LC-MS/MS Methods

• See More Publications and Case Studies

         Enroll in a Study   Current Studies   FAQ

Follow @FrontageLabs  

frontage in the MEDIA

Read media coverage of Frontage > 

2013 EVENT calendar

Let's schedule a visit at:

• AAPS National Biotechnology Conference May 20-22, San Diego, CA
• ASMS 2013 Booth 157, June 9-13, Minneapolis, MN

• Applied Pharmaceutical Analysis Sept. 16-18, Boston, MA

• 10th International ISSX Meeting Sept. 29-Oct. 3 Toronto, Canada

• CPhI Worldwide, Booth 42A11 Oct. 22-24, Frankfurt, Germany

View More Events and Conferences >